DISEASE SCANNER
Global Incurable Diseases Tracker
Gestational Trophoblastic Disease (GTD)
A group of rare tumors that involve abnormal growth of cells inside a woman's uterus that would normally develop into the placenta during pregnancy. Includes complete and partial moles.
45.0K
15
Symptoms
Treatment Options
Risk Factors
Diagnostic Methods
- 1Ultrasound (snowstorm appearance)
- 2Quantitative hCG levels (markedly elevated)
- 3Pelvic examination
- 4Chest X-ray (for metastasis)
- 5CT scan of chest/abdomen/pelvis
- 6Tissue pathology
Prognosis
Excellent. Complete mole has 15-20% risk of persistent disease; partial mole 1-4%. Cure rate for non-metastatic disease approaches 100%. Metastatic disease has 90-95% cure rate with multi-agent chemotherapy. Future fertility usually preserved. Recurrence risk 1-2% after one molar pregnancy. Subsequent pregnancies require early ultrasound monitoring.
Prevention
- No known prevention
- Early prenatal care
- Adequate nutrition in pregnancy
- HCG monitoring after molar pregnancy
Research Status
Suction dilation and curettage (D&C) for molar pregnancy. Chemotherapy for persistent or malignant GTD. Hysterectomy for women who don't want future pregnancy. Excellent cure rates with chemotherapy.
Affected Countries
Sources
- https://www.cancer.gov/types/gestational-trophoblastic/patient/gestational-treatment-pdq
- https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2018/06/gestational-trophoblastic-disease
- https://www.ncbi.nlm.nih.gov/books/NBK430886
Medical Disclaimer
This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.